Elevance Health Inc. (ELV) Tops Q3 EPS by 54c; updates Guidance

Elevance Health Inc. (NYSE: ELV) reported Q3 EPS of $8.99, $0.54 better than the analyst estimate of $8.45. Revenue for the quarter came in at $42.48 billion versus the consensus estimate of $42.76 billion.

GUIDANCE:

Elevance Health Inc. sees FY2023 adjusted EPS to be greater than $33.00, versus the consensus of $32.93.

For earnings history and earnings-related data on Elevance Health Inc. (ELV) click here.

You May Also Be Interested In

• BofA raises AMD target to $720, sees server CPU TAM tripling to $211B by 2030
• Hyperscalers need $300 billion in annual AI revenue to break even: Goldman
• Bernstein SocGen's Thoughts on McDonald's (MCD) Following Investor Day